Document and Entity Information - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Mar. 16, 2023 |
Jun. 30, 2022 |
|
| Document Information [Line Items] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“the “Original Filing”), filed with the U.S. Securities and Exchange Commission on March 16, 2023 (the “Original Filing Date”). The sole purpose of this Amendment No. 1 is to correct a typographical error in the previously filed Consent of Independent Registered Public Accounting Firm (filed as Exhibit 23.1), which inadvertently referenced the incorrect date with respect to the Report of Independent Registered Public Accounting Firm. Except as described above, no changes have been made to the Original Filing and this Amendment No. 1 does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Amendment No. 1 does not reflect events that may have occurred subsequent to the Original Filing Date. Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment No. 1 also contains a new certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which is attached hereto. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted. | ||
| Document Period End Date | Dec. 31, 2022 | ||
| Document Fiscal Year Focus | 2022 | ||
| Document Fiscal Period Focus | FY | ||
| Document Transition Report | false | ||
| Document Annual Report | true | ||
| Trading Symbol | ACHV | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Registrant Name | Achieve Life Sciences, Inc. | ||
| Entity Central Index Key | 0000949858 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Shell Company | false | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity File Number | 033-80623 | ||
| Entity Tax Identification Number | 95-4343413 | ||
| Entity Address, Address Line One | 22722 29th Drive SE | ||
| Entity Address, Address Line Two | Suite 100 | ||
| Entity Address, City or Town | Bothell | ||
| Entity Address, State or Province | WA | ||
| Entity Address, Postal Zip Code | 98021 | ||
| City Area Code | 604 | ||
| Local Phone Number | 210-2217 | ||
| Entity Common Stock, Shares Outstanding | 17,930,362 | ||
| Entity Public Float | $ 47,146,099 | ||
| Title of 12(b) Security | Common Stock, par value $0.001 per share | ||
| Security Exchange Name | NASDAQ | ||
| ICFR Auditor Attestation Flag | false | ||
| Auditor Firm ID | 271 | ||
| Auditor Name | PricewaterhouseCooopers LLP | ||
| Auditor Location | Vancouver, BC, Canada | ||
| Documents Incorporated by Reference |
Portions of the Registrant’s Definitive Proxy Statement for its 2023 Annual Meeting of Stockholders (“Proxy Statement”), to be filed within 120 days of the Registrant’s fiscal year ended December 31, 2022, is incorporated by reference into Part III of this Annual Report on Form 10-K. |
||
| Principal Address | |||
| Document Information [Line Items] | |||
| Entity Address, Address Line One | 1040 West Georgia Street | ||
| Entity Address, Address Line Two | Suite 1030 | ||
| Entity Address, City or Town | Vancouver | ||
| Entity Address, State or Province | BC | ||
| Entity Address, Postal Zip Code | V6E 4H1 |